Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2000 1
2013 1
2014 1
2020 0
Text availability
Article attribute
Article type
Publication date

Search Results

3 results
Results by year

Citations

1 article found by citation matching

Search results

Filters applied: . Clear all
Page 1
Increasing the chances for platinum-sensitive ovarian cancer patients.
González A. González A. Future Oncol. 2013 Dec;9(12 Suppl):29-35. doi: 10.2217/fon.13.204. Future Oncol. 2013. PMID: 24195528 Review.
Ovarian carcinoma is still one of the most common causes of death from cancer in the western world. Despite high sensitivity to chemotherapy, the majority of patients will relapse within 3 years. ...Promising results have been obtained with the combination of
Ovarian carcinoma is still one of the most common causes of death from cancer in the western world. Despite high sensitivity t
Chemotherapy hypersensitivity reactions in ovarian cancer.
Picard M, Matulonis UA, Castells M. Picard M, et al. J Natl Compr Canc Netw. 2014 Mar 1;12(3):389-402. doi: 10.6004/jnccn.2014.0040. J Natl Compr Canc Netw. 2014. PMID: 24616544 Review.
Ovarian cancer is the fifth leading cause of cancer death among women in the United States. Chemotherapy using a taxane and platinum combination is key in improving survival in patients with newly diagnosed advanced ovarian cancer
Ovarian cancer is the fifth leading cause of cancer death among women in the United States. Chemotherapy using a taxane
Clinical perspectives on platinum resistance.
Giaccone G. Giaccone G. Drugs. 2000;59 Suppl 4:9-17; discussion 37-8. doi: 10.2165/00003495-200059004-00002. Drugs. 2000. PMID: 10864226 Review.
The mechanisms of platinum resistance in patients are still poorly understood. Clearly, when a tumour relapses a long time after successful first-line treatment, there is a high chance that it will still be sensitive to platinum compounds. ...Ap …
The mechanisms of platinum resistance in patients are still poorly understood. Clearly, when a tumour relapses a long time aft …
Feedback